Literature DB >> 1530918

Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase).

B Zanke1, H Suzuki, K Kishihara, L Mizzen, M Minden, A Pawson, T W Mak.   

Abstract

Tyrosine phosphorylation and dephosphorylating events have been shown to be central to the process of growth regulation and signal transduction. We report here, the identification of a new gene with a tyrosine phosphatase domain (EC 3.1.3.48) which is expressed exclusively in thymus and spleen. A cDNA of 2760 bp encodes a 339-amino acid, intracellular, single-domain tyrosine phosphatase. When expressed as a glutathionine-S-transferase fusion protein, efficient lysis of p-nitrophenyl phosphate is noted, indicating in vitro enzymatic activity of the cloned gene product. Normal mouse lymphocytes increase mRNA expression 10-15-fold upon stimulation with phytohemagglutinin, concanavalin A, lipopolysaccharide or anti-CD3 monoclonal antibody. This new hematopoietic tyrosine phosphatase, (HePTP), may play a role in the regulation of T and B lymphocyte development and signal transduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530918     DOI: 10.1002/eji.1830220134

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

2.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

3.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 4.  Synaptic plasticity: one STEP at a time.

Authors:  Steven P Braithwaite; Surojit Paul; Angus C Nairn; Paul J Lombroso
Journal:  Trends Neurosci       Date:  2006-06-30       Impact factor: 13.837

Review 5.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

Review 6.  Small molecule tools for functional interrogation of protein tyrosine phosphatases.

Authors:  Rongjun He; Li-Fan Zeng; Yantao He; Sheng Zhang; Zhong-Yin Zhang
Journal:  FEBS J       Date:  2012-08-16       Impact factor: 5.542

7.  Resting and active states of the ERK2:HePTP complex.

Authors:  Dana M Francis; Bartosz Różycki; Antoni Tortajada; Gerhard Hummer; Wolfgang Peti; Rebecca Page
Journal:  J Am Chem Soc       Date:  2011-10-10       Impact factor: 15.419

8.  Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

Authors:  David A Critton; Antoni Tortajada; Geoffrey Stetson; Wolfgang Peti; Rebecca Page
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

9.  1H, 15N and 13C sequence specific backbone assignment of the vanadate inhibited hematopoietic tyrosine phosphatase.

Authors:  Luciana E S F Machado; Rebecca Page; Wolfgang Peti
Journal:  Biomol NMR Assign       Date:  2017-08-30       Impact factor: 0.746

10.  Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes.

Authors:  Jaclyn W McAlees; Virginia M Sanders
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.